Kura Oncology Inc
KURA
Get informed when a big investor buys or sells
+ FollowMarket Cap$849.57M
Close$
$15.35
54.5% upside
Current Fair Value
54.5% upsideUndervalued by 54.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $849.57 Million |
|---|---|
| Enterprise Value | $882.46 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.18 |
| Beta | 0.35 |
| Outstanding Shares | 88,610,000 |
Return
| Return on Equity | -273.05% |
|---|---|
| Return on Assets | -45.14% |
| Return on Invested Capital | -57.70% |
Valuation & Multiples
| P/E Ratio | -2.86 |
|---|---|
| PEG | -10.32 |
| Price to Sales | - |
| Price to Book Ratio | 9.94 |
| Enterprise Value to Revenue | 12.32 |
| Enterprise Value to EBIT | -2.78 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.67 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.88
Average shareholder expectationRevenue Estimate
$20.16 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-0.95
Average shareholder expectationRevenue Estimate
$23.39 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 99.91% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 23.73%▼ 71.50% |
|---|---|
| Total Invested | $230.20M▼ 66.45% |
| Investors Holding | 75▼ 151.00% |
ESG Score
No data
About Kura Oncology Inc
CEO: Troy Wilson